Skip to main content

Mass General Brigham, Inc

SEC CIK
0001678378
Latest filing
Aug 7, 2026

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Oct 8, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
7
−2 vs. Q2 2021
Portfolio value
$370.6M
−$39.3M (−9.6%) vs. Q2 2021
Filed
Oct 8, 2021
SEC
Holdings of Mass General Brigham, Inc in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
iShares Core S&P 500 ETF464287200ETF468,707$201.9M54.5%−50,054−9.6%Reduced–
iShares Core U.S. Aggregate Bond ETF464287226ETF1,158,777$133.1M35.9%−106,626−8.4%Reduced–
COINCoinbase Global, Inc.COM CL A128,947$29.3M7.9%00.0%UnchangedHistory
PDDPDD Holdings Inc.SPONSORED ADS44,184$4.01M1.1%+8,834+25.0%AddedHistory
XPEVXpeng Inc.ADS38,370$1.36M0.4%+38,370NewHistory
NRIXNurix Therapeutics, Inc.COM15,904$476.0K0.1%+15,904NewHistory
FULCFulcrum Therapeutics, Inc.COM15,860$447.0K0.1%+15,860NewHistory

Sold out since Q2 2021 (5)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Mass General Brigham, Inc sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
DOCUDocuSign, Inc.Stock4,003$1.12M0.3%History
SNOWSnowflake Inc.Stock4,496$1.09M0.3%History
CRSPCRISPR Therapeutics AGNAMEN AKT6,464$1.05M0.3%History
DELLDell Technologies Inc.Stock4,039$403.0K0.1%History
JNCEJounce Therapeutics, Inc.COM19,291$131.0K<0.1%History